Cancer innovation in ‘era of fear’: New AI tools meet old access barriers — and new funding cuts
Advances in AI, genomics, and liquid biopsy are reshaping cancer care, but systemic gaps persist in access and funding, experts say.
Innovation in cancer detection, treatment, and prevention is stirring excitement today, accelerated by advances in artificial intelligence and other technological tools wielded by scientists, physicians, and even patients. Still, serious gaps remain between theory and reality, experts said Tuesday.
There’s a gap in access. There’s a gap between clinical guidance and clinical practice. Then there’s a gap in federal funding for the academic engine that speeds ideas into practice, a panel of health advocates and leaders from pharma and the liquid biopsy industry said Tuesday.
